Applied Filters
United Therapeutics signs 3D bioprinting technology deal
Maryland-based United Therapeutics has inked a licence, development and commercialisation agreement with CollPlant, an Israeli biotech company, for 3D bioprinted lung transplants.
Novartis signs deal to bring CAR T therapy to China
Novartis has teamed up with a clinical-stage biopharmaceutical firm in efforts to bring the Swiss company’s proprietary cancer treatment to patients in China.
Bombay court finds company liable for infringing Glenmark TM
The Bombay High Court has imposed Rs 1.5 crore of costs on a pharmaceutical company which infringed India-based Glenmark Pharmaceuticals’ trademarks.
Chinese individuals indicted for stealing US rice technology
Two Chinese nationals have been charged with conspiracy to steal rice technology from a US-based biotechnology company.
Almirall to acquire Allergan dermatology portfolio
Spain-based pharmaceutical company Almirall will acquire Allergan’s dermatology portfolio.
AbbVie faces hepatitis C patent challenge in India
In India, a non-profit organisation and an advocacy group have united to take on a patent covering pibrentasvir, part of the drug combination that forms AbbVie’s hepatitis C product Mavyret.
Sun Pharma unit bolsters patent suit with trade secrets claims
Dusa Pharmaceuticals, a subsidiary of India-based generic drug maker Sun Pharma, has accused dermatology-focused company Biofrontera of misappropriating trade secrets.
US tariffs on med tech prevent patient access: trade association
A medical technology trade association has warned that the US tariffs recently implemented in response to Chinese IP theft may hinder patient access to life-saving technologies.
US leading the way in patent filings for applications of synthetic biology: PatSnap
The US is leading the way in synthetic biology patent filings, according to a report released earlier this month from patent search software company PatSnap.
MSF challenges Gilead patent in China
Humanitarian organisation Médecins Sans Frontières has challenged a patent owned by Gilead in China.
